{"DataElement":{"publicId":"7283674","version":"1","preferredName":"Primary Disease Site Histologic Type Name","preferredDefinition":"Descriptive name of the primary disease site which may include histotype.","longName":"DZSITE_TYPE","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7283667","version":"1","preferredName":"Primary Site of Disease Histologic Type","preferredDefinition":"The primary site of a disease of interest._Refers to the type of tissue in which a tumor originated.","longName":"7283665v1.0:2673286v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"7283665","version":"1","preferredName":"Primary Site of Disease","preferredDefinition":"The primary site of a disease of interest.","longName":"C158874","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Site of Disease","conceptCode":"C158874","definition":"The anatomic location where a disease of interest originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FB38F6-C00F-7A21-E053-F662850A8A1B","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FB38F6-C01D-7A21-E053-F662850A8A1B","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"TAYLORT","dateModified":"2020-05-07","changeDescription":"5-7-20 tmt released/MM. 5-6-20 NCICOVID NSV; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7283669","version":"1","preferredName":"Primary Site of Disease Histologic Type Name","preferredDefinition":"The primary site of a disease of interest._Refers to the type of tissue in which a tumor originated._The words or language units by which a thing is known.","longName":"DZSITE_TYP_NM","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"LEUKEMIA: CHRONIC LYMPHOCYTIC","valueDescription":"Chronic Lymphocytic Leukemia","ValueMeaning":{"publicId":"4264837","version":"1","preferredName":"Chronic Lymphocytic Leukemia","longName":"4264837","preferredDefinition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FFD5-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38C5-2E79-186F-E053-F662850A63BF","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"MERKEL CELL","valueDescription":"Merkel Cell Carcinoma","ValueMeaning":{"publicId":"3210716","version":"1","preferredName":"Merkel Cell Carcinoma","longName":"3210716","preferredDefinition":"A rare malignant cutaneous tumor seen in elderly patients.  Its usual location is on the head, neck and extremities.  The tumor is composed of small round cells with scanty cytoplasm arranged in a trabecular pattern, or in ill-defined nodules or in a diffuse pattern.  The tumor cells contain cytoplasmic membrane-bound dense core granules resembling neurosecretory granules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma","conceptCode":"C9231","definition":"A rare aggressive neuroendocrine carcinoma that usually arises from the skin. Rarely, it arises from extracutaneous sites, including the oral cavity, salivary glands, breast, vulva, and vaginal wall. The tumor is composed of small round cells with scanty cytoplasm. Merkel cell polyomavirus is implicated in the majority of cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-935E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38C5-2E8F-186F-E053-F662850A63BF","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"MELANOMA","valueDescription":"Melanoma","ValueMeaning":{"publicId":"5581342","version":"1","preferredName":"Melanoma","longName":"5581342","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38C5-2EA3-186F-E053-F662850A63BF","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"BREAST: NOT OTHERWISE SPECIFIED","valueDescription":"Breast Carcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"3590101","version":"1","preferredName":"Breast Carcinoma Not Otherwise Specified","longName":"3590101","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA116DCD-3603-3F6C-E040-BB89AD430A5B","latestVersionIndicator":"Yes","beginDate":"2012-09-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-09-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FBA12E-B41C-4C5E-E053-F662850ADD2C","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"SKIN: SQUAMOUS CELL","valueDescription":"Skin Squamous Cell Carcinoma","ValueMeaning":{"publicId":"4722553","version":"1","preferredName":"Skin Squamous Cell Carcinoma","longName":"4722553","preferredDefinition":"A carcinoma arising from the squamous cells of the epidermis.  Skin squamous cell carcinoma is most commonly found on sun-exposed areas.  The majority of the tumors are well-differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Squamous Cell Carcinoma","conceptCode":"C4819","definition":"A carcinoma arising from the squamous cells of the epidermis.  Skin squamous cell carcinoma is most commonly found on sun-exposed areas.  The majority of the tumors are well-differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B5E9-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FBA12E-B433-4C5E-E053-F662850ADD2C","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"BLADDER","valueDescription":"Bladder Urothelial Carcinoma","ValueMeaning":{"publicId":"6859301","version":"1","preferredName":"Bladder Urothelial Carcinoma","longName":"6859301","preferredDefinition":"The most common morphologic subtype of urinary bladder carcinoma (over 90% of cases).  It arises from the transitional epithelium.  It most often affects males in their sixth and seventh decades of life.  Hematuria is the most common symptom at presentation.  Pathologic stage is the strongest predictor of survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Urothelial Carcinoma","conceptCode":"C39851","definition":"A carcinoma that arises from the urothelial lining of the bladder.  It is the most common morphologic type of urinary bladder carcinoma. It usually affects males in their sixth and seventh decades of life.  Hematuria is the most common symptom at presentation. Pathologic stage is the strongest predictor of survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A89662-E39B-6A17-E053-F662850A8154","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB619F-DAC4-16FE-E053-F662850A8401","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"ANUS","valueDescription":"Anus","ValueMeaning":{"publicId":"3625363","version":"1","preferredName":"Anus","longName":"3625363","preferredDefinition":"The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anus","conceptCode":"C43362","definition":"The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDEA95FE-138E-6872-E040-BB89AD431F96","latestVersionIndicator":"Yes","beginDate":"2012-11-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-07","modifiedBy":"ONEDATA","dateModified":"2012-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB619F-DACE-16FE-E053-F662850A8401","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"BREAST: DUCTAL","valueDescription":"Ductal Breast Carcinoma","ValueMeaning":{"publicId":"2838039","version":"1","preferredName":"Ductal Breast Carcinoma","longName":"2838039","preferredDefinition":"A carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma, not otherwise specified.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma","conceptCode":"C4017","definition":"A breast carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast. Ductal carcinomas account for about two thirds of all breast cancers. Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive breast carcinoma of no special type. The latter often spreads to the axillary lymph nodes and other anatomic sites. The two forms of ductal carcinoma often coexist.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62837FF7-84E7-6F46-E040-BB89AD433964","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB619F-DAE5-16FE-E053-F662850A8401","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LYMPHOMA: HODGKIN","valueDescription":"Hodgkin Lymphoma","ValueMeaning":{"publicId":"4981811","version":"1","preferredName":"Hodgkin Lymphoma","longName":"4981811","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of large tumor cells in an abundant admixture of nonneoplastic cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E139787-9898-E8CC-E050-BB89AD435F1A","latestVersionIndicator":"Yes","beginDate":"2015-08-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB619F-DAFB-16FE-E053-F662850A8401","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LYMPHOMA: NOT OTHERWISE SPECIFIED","valueDescription":"Lymphoma Not Otherwise Specified","ValueMeaning":{"publicId":"7283672","version":"1","preferredName":"Lymphoma Not Otherwise Specified","longName":"7283672","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FC5A85-E6D5-7A19-E053-F662850AF03A","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC5A85-E6F0-7A19-E053-F662850AF03A","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"MULTIPLE MYELOMA","valueDescription":"Plasma Cell Myeloma","ValueMeaning":{"publicId":"5581351","version":"1","preferredName":"Plasma Cell Myeloma","longName":"5581351","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B9DD-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC5A85-E706-7A19-E053-F662850AF03A","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"ESOPHAGUS: ADENOCARCINOMA","valueDescription":"Esophageal Adenocarcinoma","ValueMeaning":{"publicId":"4722733","version":"1","preferredName":"Esophageal Adenocarcinoma","longName":"4722733","preferredDefinition":"A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus.  Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported.  Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas.  Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Adenocarcinoma","conceptCode":"C4025","definition":"A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus.  Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported.  Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas.  Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1E4D-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38F6-C03F-7A21-E053-F662850A8A1B","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"COLORECTAL","valueDescription":"Colorectal","ValueMeaning":{"publicId":"4265336","version":"1","preferredName":"Colorectal","longName":"4265336","preferredDefinition":"Relating to the colon and rectum, or to the entire large bowel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal","conceptCode":"C13363","definition":"Relating to the colon and rectum, or to the entire large bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F694966F-2F8B-D003-E040-BB89AD430DBC","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38F6-C053-7A21-E053-F662850A8A1B","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"CERVIX","valueDescription":"Cervix Uteri","ValueMeaning":{"publicId":"3412468","version":"1","preferredName":"Cervix Uteri","longName":"3412468","preferredDefinition":"The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervix Uteri","conceptCode":"C12311","definition":"The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAD632BC-ACA2-6458-E040-BB89AD431BBB","latestVersionIndicator":"Yes","beginDate":"2012-03-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-03-09","modifiedBy":"FINCHAMB","dateModified":"2023-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38F6-C068-7A21-E053-F662850A8A1B","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LEUKEMIA: ACUTE LYMPHOBLASTIC/LYMPHOCYTIC","valueDescription":"Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"3322383","version":"1","preferredName":"Acute Lymphoblastic Leukemia","longName":"3322383","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB5D-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38F6-C07F-7A21-E053-F662850A8A1B","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"KIDNEY","valueDescription":"Kidney","ValueMeaning":{"publicId":"2567242","version":"1","preferredName":"Kidney","longName":"2567242","preferredDefinition":"One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney","conceptCode":"C12415","definition":"One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secrete metabolic products and minerals from the blood, thus maintaining homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3B7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38F6-C089-7A21-E053-F662850A8A1B","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"HEAD AND NECK","valueDescription":"Head and Neck","ValueMeaning":{"publicId":"4320227","version":"1","preferredName":"Head and Neck","longName":"4320227","preferredDefinition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F975C05E-645E-B624-E040-BB89AD432676","latestVersionIndicator":"Yes","beginDate":"2014-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB38F6-C093-7A21-E053-F662850A8A1B","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"BREAST: LOBULAR","valueDescription":"Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2957350","version":"1","preferredName":"Lobular Breast Carcinoma","longName":"2957350","preferredDefinition":"An adenocarcinoma of the breast arising from the lobules.  This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma","conceptCode":"C3771","definition":"An adenocarcinoma of the breast arising from the lobules.  This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"770B3885-67E3-5BD6-E040-BB89AD4371E9","latestVersionIndicator":"Yes","beginDate":"2009-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-28","modifiedBy":"ONEDATA","dateModified":"2009-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB93BC-7A45-1D2A-E053-F662850ACFDA","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"BRAIN","valueDescription":"Brain Central Nervous System","ValueMeaning":{"publicId":"6763896","version":"1","preferredName":"Brain Central Nervous System","longName":"6763896","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.: The part of the nervous system that consists of the brain, spinal cord, and meninges.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"896AC178-3030-077D-E053-F662850A06B7","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-21","modifiedBy":"ONEDATA","dateModified":"2019-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB7E0B-F801-1FA9-E053-F662850A328C","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LEUKEMIA: CHRONIC MYELOID","valueDescription":"Chronic Myeloid Leukemia Pathway","ValueMeaning":{"publicId":"7283671","version":"1","preferredName":"Chronic Myeloid Leukemia Pathway","longName":"7283671","preferredDefinition":"Chronic myelogenous leukaemia (CML) is a biphasic disease, initiated by expression of the BCR/ABL fusion gene product in self-renewing, haematopoietic stem cells (HSCs). HSCs can differentiate into common myeloid progenitors (CMPs), which then differentiate into granulocyte/macrophage progenitors (GMPs). HSCs can also differentiate into common lymphoid progenitors (CLPs), which are the progenitors of lymphocytes such as T cells and B cells. The initial chronic phase of CML (CML-CP) is characterized by a massive expansion of the granulocytic-cell series. Acquisition of additional genetic mutations beyond expression of BCR/ABL causes the progression of CML from chronic phase to blast phase (CML-BP), characterized by an accumulation of myeloid or lymphoid blast cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Myeloid Leukemia Pathway","conceptCode":"C91465","definition":"Chronic myelogenous leukaemia (CML) is a biphasic disease, initiated by expression of the BCR/ABL fusion gene product in self-renewing, haematopoietic stem cells (HSCs). HSCs can differentiate into common myeloid progenitors (CMPs), which then differentiate into granulocyte/macrophage progenitors (GMPs). HSCs can also differentiate into common lymphoid progenitors (CLPs), which are the progenitors of lymphocytes such as T cells and B cells. The initial chronic phase of CML (CML-CP) is characterized by a massive expansion of the granulocytic-cell series. Acquisition of additional genetic mutations beyond expression of BCR/ABL causes the progression of CML from chronic phase to blast phase (CML-BP), characterized by an accumulation of myeloid or lymphoid blast cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FB7198-35A9-7A25-E053-F662850AD730","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB7198-35C4-7A25-E053-F662850AD730","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LEUKEMIA: NOT OTHERWISE SPECIFIED","valueDescription":"Leukemia Not Otherwise Specified","ValueMeaning":{"publicId":"3323200","version":"1","preferredName":"Leukemia Not Otherwise Specified","longName":"3323200","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3724AB2-AF77-5E8E-E040-BB89AD433884","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC1DB2-4595-7A0D-E053-F662850A6C21","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LYMPHOMA: FOLLICULAR","valueDescription":"Follicular Lymphoma","ValueMeaning":{"publicId":"3088584","version":"1","preferredName":"Follicular Lymphoma","longName":"3088584","preferredDefinition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Lymphoma","conceptCode":"C3209","definition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E3DD57-D19B-A26A-E040-BB89AD437117","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-05-18","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC419B-6C9B-7A11-E053-F662850A879A","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LUNG: SMALL CELL","valueDescription":"Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3297699","version":"1","preferredName":"Small Cell Lung Carcinoma","longName":"3297699","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B035F07A-837C-9251-E040-BB89AD4303FC","latestVersionIndicator":"Yes","beginDate":"2011-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC419B-6CB1-7A11-E053-F662850A879A","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LUNG: SQUAMOUS CELL","valueDescription":"Squamous Cell Lung Carcinoma","ValueMeaning":{"publicId":"2956083","version":"1","preferredName":"Squamous Cell Lung Carcinoma","longName":"2956083","preferredDefinition":"A carcinoma arising from malignant squamous bronchial epithelial cells and characterized by the presence of keratinization and/or intercellular bridges.  Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma","conceptCode":"C3493","definition":"A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B835-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC1DB2-45AB-7A0D-E053-F662850A6C21","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LUNG: NOT OTHERWISE SPECIFIED","valueDescription":"Lung Carcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"3323202","version":"1","preferredName":"Lung Carcinoma Not Otherwise Specified","longName":"3323202","preferredDefinition":"A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. -- 2004: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3724AB2-AFBF-5E8E-E040-BB89AD433884","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC419B-6CC7-7A11-E053-F662850A879A","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"SKIN: BASAL CELL","valueDescription":"Skin Basal Cell Carcinoma","ValueMeaning":{"publicId":"2961462","version":"1","preferredName":"Skin Basal Cell Carcinoma","longName":"2961462","preferredDefinition":"The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like.. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Basal Cell Carcinoma","conceptCode":"C2921","definition":"The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78AB07DC-B5C7-F05E-E040-BB89AD43180B","latestVersionIndicator":"Yes","beginDate":"2009-11-18","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC90AF-632A-156B-E053-F662850A1276","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"SARCOMA","valueDescription":"Sarcoma","ValueMeaning":{"publicId":"4265252","version":"1","preferredName":"Sarcoma","longName":"4265252","preferredDefinition":"A malignant mesenchymal tumor for which a distinct line of differentiation cannot be determined. This term may be used for small biopsy specimens for which adequate tissue is not present for definitive classification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4B91-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC90AF-633E-156B-E053-F662850A1276","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"SKIN: NOT OTHERWISE SPECIFIED","valueDescription":"Skin Carcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"7283673","version":"1","preferredName":"Skin Carcinoma Not Otherwise Specified","longName":"7283673","preferredDefinition":"Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin).: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Carcinoma","conceptCode":"C4914","definition":"A carcinoma that arises from the skin.  Representative examples are basal cell carcinoma and squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FC90AF-634C-156B-E053-F662850A1276","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC90AF-6367-156B-E053-F662850A1276","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"STOMACH","valueDescription":"Stomach","ValueMeaning":{"publicId":"3284854","version":"1","preferredName":"Stomach","longName":"3284854","preferredDefinition":"An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stomach","conceptCode":"C12391","definition":"The primary organ of food digestion. It is located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADA2A8AB-93AA-8579-E040-BB89AD430C42","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"FINCHAMB","dateModified":"2023-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FCA081-4864-7DCB-E053-F662850A6B82","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"OTHER","valueDescription":"Specify Other","ValueMeaning":{"publicId":"6782229","version":"1","preferredName":"Specify Other","longName":"6782229","preferredDefinition":"A directive to indicate a response not listed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify Other","conceptCode":"C157106","definition":"A directive to indicate a response not listed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-90A3-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"TSESU","dateModified":"2022-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC90AF-637D-156B-E053-F662850A1276","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"UTERUS","valueDescription":"Uterus","ValueMeaning":{"publicId":"2567250","version":"1","preferredName":"Uterus","longName":"2567250","preferredDefinition":"A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterus","conceptCode":"C12405","definition":"A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3BF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC90AF-6388-156B-E053-F662850A1276","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"THYROID","valueDescription":"Thyroid Gland","ValueMeaning":{"publicId":"3284856","version":"1","preferredName":"Thyroid Gland","longName":"3284856","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADA2A8AB-93F0-8579-E040-BB89AD430C42","latestVersionIndicator":"Yes","beginDate":"2011-09-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-23","modifiedBy":"FINCHAMB","dateModified":"2023-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FC90AF-639D-156B-E053-F662850A1276","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"ESOPHAGUS: SQUAMOUS CELL","valueDescription":"Esophageal Squamous Cell Carcinoma","ValueMeaning":{"publicId":"4722729","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma","longName":"4722729","preferredDefinition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Squamous Cell Carcinoma","conceptCode":"C4024","definition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1DC4-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D341-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LEUKEMIA: ACUTE MYELOID","valueDescription":"Acute Myeloid Leukemia","ValueMeaning":{"publicId":"4263972","version":"1","preferredName":"Acute Myeloid Leukemia","longName":"4263972","preferredDefinition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1110-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D380-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"ESOPHAGUS: NOT OTHERWISE SPECIFIED","valueDescription":"Esophageal Carcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"7283670","version":"1","preferredName":"Esophageal Carcinoma Not Otherwise Specified","longName":"7283670","preferredDefinition":"A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Carcinoma","conceptCode":"C3513","definition":"A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FB5220-D34F-7A15-E053-F662850AA921","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D36A-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LYMPHOMA: DIFFUSE LARGE B CELL","valueDescription":"Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"2838040","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma","longName":"2838040","preferredDefinition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62837FF7-850A-6F46-E040-BB89AD433964","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SOKKERL","dateModified":"2018-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D396-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LUNG: ADENOCARCINOMA","valueDescription":"Lung Adenocarcinoma","ValueMeaning":{"publicId":"3106713","version":"1","preferredName":"Lung Adenocarcinoma","longName":"3106713","preferredDefinition":"A carcinoma characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma","conceptCode":"C3512","definition":"A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D4B-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D3AC-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"LIVER","valueDescription":"Liver","ValueMeaning":{"publicId":"3412526","version":"1","preferredName":"Liver","longName":"3412526","preferredDefinition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAD6DAA6-A548-5819-E040-BB89AD434BA6","latestVersionIndicator":"Yes","beginDate":"2012-03-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-03-09","modifiedBy":"KUMMEROA","dateModified":"2022-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D3B6-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"PROSTATE","valueDescription":"Prostate Gland","ValueMeaning":{"publicId":"3123671","version":"1","preferredName":"Prostate Gland","longName":"3123671","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC1C923-9B52-5F51-E040-BB89AD4331F6","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D3CD-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"},{"value":"PANCREAS","valueDescription":"Pancreas","ValueMeaning":{"publicId":"3297613","version":"1","preferredName":"Pancreas","longName":"3297613","preferredDefinition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreas","conceptCode":"C12393","definition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0262734-8F09-136C-E040-BB89AD433212","latestVersionIndicator":"Yes","beginDate":"2011-10-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-25","modifiedBy":"COOPERM","dateModified":"2018-04-05","changeDescription":"Updated concept definition to match current NCIt. 4.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A4FB5220-D3D8-7A15-E053-F662850AA921","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7283668","version":"1","preferredName":"Primary Site of Disease Histologic Type Name","preferredDefinition":"The primary site of a disease of interest.:Refers to the type of tissue in which a tumor originated.:The words or language units by which a thing is known.","longName":"C158874:C61478:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Site of Disease","conceptCode":"C158874","definition":"The anatomic location where a disease of interest originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FB5220-D303-7A15-E053-F662850AA921","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FB5220-D314-7A15-E053-F662850AA921","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"TAYLORT","dateModified":"2020-05-07","changeDescription":"5-7-20 tmt released/MM. 5-6-20 NCICOVID NSV; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Primary disease site/histolog","type":"Preferred Question Text","description":"Primary disease site/histologic type","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4FCDFD9-37E4-7A29-E053-F662850A950F","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-05-06","modifiedBy":"TAYLORT","dateModified":"2020-05-07","changeDescription":"5-7-20 tmt released/MM. 5-6-20 NCICOVID NSV; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}